Literature DB >> 12878296

Etiologic yield of cerebral palsy: a contemporary case series.

Michael I Shevell1, Annette Majnemer, Isabelle Morin.   

Abstract

Cerebral palsy is an established symptom complex that results from heterogeneous etiologies. Our understanding of the relative contribution of underlying etiologies to the occurrence of cerebral palsy is largely derived from studies lacking systematic neurologic evaluation or the application of contemporary imaging modalities. Throughout a 10-year inclusive period, the case records of all consecutive patients diagnosed with cerebral palsy in a single pediatric neurology practice were reviewed with reference to clinical features and diagnostic yield. A total of 217 cases of cerebral palsy were identified (129 male, 88 female): 77 (35.5%) spastic quadriplegic, 68 (31.3%) spastic hemiplegic, 39 (18%) spastic diplegic, five (2.7%) spastic monoplegic, 12 (5.5%) mixed, 12 (5.5%) ataxic-hypotonic, two (0.9%) dyskinetic, two (0.9%) Worster-Drought syndrome. Overall etiologic yield was 82.0%, varying according to type of cerebral palsy: 50% dyskinetic, 59% diplegia, 80% monoplegia, 80.9% hemiplegia, 90.9% quadriplegia, 91.7% ataxic hypotonia, and 100% mixed/Woster-Drought. The top five etiologic entities identified were periventricular leukomalacia, 24.9%; intrapartum asphyxia, 21.7%; cerebral dysgenesis, 17.1%; intracranial hemorrhage, 12.9%; and vascular, 9.7%. Although a single etiology was apparent in 144 (66.4%) of the cases, multiple etiologies were believed to be contributory in 34 (15.6%) of the cases. The etiologic profile varied according to such features as the type of cerebral palsy, gestational age, and the source (high-risk neonatal population or not) of the patients. Features of the child's cerebral palsy, such as microcephaly, neonatal difficulties, prior or coexisting epilepsy, and high-risk source, were found to be predictive of eventual etiologic yield. This contemporary evaluation of cerebral palsy etiologic yield suggests that it is much higher than previously reported and varies, depending on key clinical features.

Entities:  

Mesh:

Year:  2003        PMID: 12878296     DOI: 10.1016/s0887-8994(03)00006-7

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  12 in total

1.  Genome-wide oligonucleotide array comparative genomic hybridization for etiological diagnosis of mental retardation: a multicenter experience of 1499 clinical cases.

Authors:  Bixia Xiang; Hongbo Zhu; Yiping Shen; David T Miller; Kangmo Lu; Xiaofeng Hu; Hans C Andersson; Tarachandra M Narumanchi; Yueying Wang; Jose E Martinez; Bai-Lin Wu; Peining Li; Marilyn M Li; Tian-Jian Chen; Yao-Shan Fan
Journal:  J Mol Diagn       Date:  2010-01-21       Impact factor: 5.568

2.  Risk factors associated with epilepsy development in children with cerebral palsy.

Authors:  Elif Karatoprak; Gülhan Sözen; Sema Saltık
Journal:  Childs Nerv Syst       Date:  2019-04-22       Impact factor: 1.475

Review 3.  Prevalence of ataxia in children: a systematic review.

Authors:  Kristin E Musselman; Cristina T Stoyanov; Rhul Marasigan; Mary E Jenkins; Jürgen Konczak; Susanne M Morton; Amy J Bastian
Journal:  Neurology       Date:  2013-11-27       Impact factor: 9.910

4.  Intrauterine growth restriction improves cerebral O2 utilization during hypercapnic hypoxia in newborn piglets.

Authors:  Reinhard Bauer; Bernd Walter; Ulrich Brandl
Journal:  J Physiol       Date:  2007-08-23       Impact factor: 5.182

5.  Clinical correlations in cerebral palsy.

Authors:  Ioana Minciu
Journal:  Maedica (Buchar)       Date:  2012-12

6.  Practice parameter: Evaluation of the child with microcephaly (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.

Authors:  Stephen Ashwal; David Michelson; Lauren Plawner; William B Dobyns
Journal:  Neurology       Date:  2009-09-15       Impact factor: 9.910

7.  A diagnostic approach for cerebral palsy in the genomic era.

Authors:  Ryan W Lee; Andrea Poretti; Julie S Cohen; Eric Levey; Hilary Gwynn; Michael V Johnston; Alexander H Hoon; Ali Fatemi
Journal:  Neuromolecular Med       Date:  2014-10-04       Impact factor: 3.843

8.  Cerebral palsy in children in Kampala, Uganda: clinical subtypes, motor function and co-morbidities.

Authors:  Angelina Kakooza-Mwesige; Hans Forssberg; Ann-Christin Eliasson; James K Tumwine
Journal:  BMC Res Notes       Date:  2015-04-23

9.  Therapeutic potential of umbilical cord mesenchymal stromal cells transplantation for cerebral palsy: a case report.

Authors:  Liming Wang; Haijie Ji; Jianjun Zhou; Jiang Xie; Zhanqiang Zhong; Ming Li; Wen Bai; Na Li; Zijia Zhang; Xuejun Wang; Delin Zhu; Yongjun Liu; Mingyuan Wu
Journal:  Case Rep Transplant       Date:  2013-03-03

Review 10.  Periventricular leucomalacia: a review.

Authors:  Ivan Blumenthal
Journal:  Eur J Pediatr       Date:  2004-06-04       Impact factor: 3.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.